DE60124791D1 - S-Methyl-Dihydro-Ziprasidone zur Behandlung von psychiatrischen Störungen. - Google Patents

S-Methyl-Dihydro-Ziprasidone zur Behandlung von psychiatrischen Störungen.

Info

Publication number: DE60124791D1
Authority: DE; Germany
Prior art keywords: ziprasidone; dihydro; methyl; treatment; psychiatric disorders
Prior art date: 2000-06-02
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

DE60124791T

Other languages

English (en)

Other versions

DE60124791T2 (de

Inventor

Chandra Prakash

Teresa Annette Smolarek

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Pfizer Products Inc

Original Assignee

Pfizer Products Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-06-02

Filing date

2001-05-28

Publication date

2007-01-04

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26903852&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60124791(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-05-28 Application filed by Pfizer Products Inc filed Critical Pfizer Products Inc

2007-01-04 Application granted granted Critical

2007-01-04 Publication of DE60124791D1 publication Critical patent/DE60124791D1/de

2007-09-13 Publication of DE60124791T2 publication Critical patent/DE60124791T2/de

2021-05-29 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Epidemiology (AREA)
Psychiatry (AREA)
Ophthalmology & Optometry (AREA)
Emergency Medicine (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Vascular Medicine (AREA)
Psychology (AREA)
Anesthesiology (AREA)
Cardiology (AREA)
Urology & Nephrology (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)
Hydrogenated Pyridines (AREA)
Medicinal Preparation (AREA)
Plural Heterocyclic Compounds (AREA)

DE60124791T 2000-06-02 2001-05-28 S-Methyl-Dihydro-Ziprasidone zur Behandlung von psychiatrischen Störungen. Expired - Fee Related DE60124791T2 (de)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date
US20913600P	2000-06-02	2000-06-02
US209136P		2000-06-02
US21217200P	2000-06-16	2000-06-16
US212172P		2000-06-16

Publications (2)

Publication Number	Publication Date
DE60124791D1 true DE60124791D1 (de)	2007-01-04
DE60124791T2 DE60124791T2 (de)	2007-09-13

Family

ID=26903852

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
DE60133596T Expired - Lifetime DE60133596D1 (de)	2000-06-02	2001-05-28	S-Methyl-Dihydro-Ziprasidone für die Behandlung von Schizophrenie
DE60124791T Expired - Fee Related DE60124791T2 (de)	2000-06-02	2001-05-28	S-Methyl-Dihydro-Ziprasidone zur Behandlung von psychiatrischen Störungen.
DE60124093T Expired - Lifetime DE60124093D1 (de)	2000-06-02	2001-05-28	S-methyl-dihydro-ziprasidon zur Behandlung von Augenerkrankungen.

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DE60133596T Expired - Lifetime DE60133596D1 (de)	2000-06-02	2001-05-28	S-Methyl-Dihydro-Ziprasidone für die Behandlung von Schizophrenie

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
DE60124093T Expired - Lifetime DE60124093D1 (de)	2000-06-02	2001-05-28	S-methyl-dihydro-ziprasidon zur Behandlung von Augenerkrankungen.

Country Status (44)

Country	Link
US (1)	US20060287336A1 (de)
EP (3)	EP1698338B1 (de)
JP (2)	JP2003534381A (de)
KR (1)	KR20030007824A (de)
CN (1)	CN1431901A (de)
AP (2)	AP1831A (de)
AR (1)	AR028937A1 (de)
AT (3)	ATE391507T1 (de)
AU (1)	AU2001258690A1 (de)
BG (1)	BG107267A (de)
BR (1)	BR0111271A (de)
CA (1)	CA2410618A1 (de)
CY (1)	CY1105992T1 (de)
CZ (1)	CZ20023860A3 (de)
DE (3)	DE60133596D1 (de)
DK (1)	DK1468686T3 (de)
DO (1)	DOP2001000181A (de)
EA (1)	EA007068B1 (de)
EC (1)	ECSP024369A (de)
EE (1)	EE200200670A (de)
ES (1)	ES2277170T3 (de)
GE (1)	GEP20053512B (de)
HN (1)	HN2001000119A (de)
HR (1)	HRP20020953A2 (de)
HU (1)	HUP0301747A2 (de)
IL (2)	IL152782A0 (de)
IS (1)	IS6619A (de)
MA (1)	MA26908A1 (de)
MX (1)	MXPA02011862A (de)
NO (1)	NO325077B1 (de)
NZ (1)	NZ551012A (de)
OA (1)	OA12267A (de)
PA (1)	PA8518301A1 (de)
PE (1)	PE20011329A1 (de)
PL (1)	PL365576A1 (de)
PT (2)	PT1468686E (de)
SI (1)	SI1468686T1 (de)
SK (1)	SK16622002A3 (de)
SV (1)	SV2002000473A (de)
UA (1)	UA79425C2 (de)
UY (1)	UY26742A1 (de)
WO (1)	WO2001091756A2 (de)
YU (1)	YU90702A (de)
ZA (1)	ZA200209665B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7419493B2 (en)	2002-12-13	2008-09-02	Regents Of The University Of Minnesota	Scleral depressor
WO2005040160A2 (en)	2003-10-24	2005-05-06	Teva Pharmaceutical Industries Ltd.	Processes for preparation of ziprasidone
ES2250001B1 (es) *	2004-09-29	2007-06-01	Medichem, S.A.	Proceso para la purificacion de ziprasidona.
JP2012174228A (ja) *	2011-02-24	2012-09-10	Kyocera Corp	プログラム保護装置および通信装置
US20140206667A1 (en)	2012-11-14	2014-07-24	Michela Gallagher	Methods and compositions for treating schizophrenia
US9981041B2 (en) *	2016-08-23	2018-05-29	Ira Jason Salzman	Ophthalmic lubricating spray

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ508303A (en) *	1996-05-07	2001-07-27	Pfizer	Mesylate trihydrate salt of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2(1H)-indol-2-one (ziprasidone) useful as a dopamine D2 antagonist
TW491847B (en) *	1996-05-07	2002-06-21	Pfizer	Mesylate dihydrate salts of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one
DK0985414T3 (da) *	1998-05-26	2003-12-29	Pfizer Prod Inc	Lægemiddel til behandling af glaukome og iskæmisk retinopati
CA2363942A1 (en) *	1999-04-06	2000-10-12	Sepracor Inc.	Methods and compositions for the treatment of psychotic and related disorders using ziprasidone metabolites

2001
- 2001-05-28 DE DE60133596T patent/DE60133596D1/de not_active Expired - Lifetime
- 2001-05-28 YU YU90702A patent/YU90702A/sh unknown
- 2001-05-28 PT PT04013380T patent/PT1468686E/pt unknown
- 2001-05-28 AT AT06116051T patent/ATE391507T1/de not_active IP Right Cessation
- 2001-05-28 KR KR1020027016364A patent/KR20030007824A/ko not_active Ceased
- 2001-05-28 SK SK1662-2002A patent/SK16622002A3/sk not_active Application Discontinuation
- 2001-05-28 DE DE60124791T patent/DE60124791T2/de not_active Expired - Fee Related
- 2001-05-28 SI SI200130681T patent/SI1468686T1/sl unknown
- 2001-05-28 OA OA1200200349A patent/OA12267A/en unknown
- 2001-05-28 EE EEP200200670A patent/EE200200670A/xx unknown
- 2001-05-28 PT PT06116051T patent/PT1698338E/pt unknown
- 2001-05-28 UA UA2002119557A patent/UA79425C2/uk unknown
- 2001-05-28 GE GE4972A patent/GEP20053512B/en unknown
- 2001-05-28 EA EA200201168A patent/EA007068B1/ru not_active IP Right Cessation
- 2001-05-28 HR HR20020953A patent/HRP20020953A2/hr not_active Application Discontinuation
- 2001-05-28 EP EP06116051A patent/EP1698338B1/de not_active Expired - Lifetime
- 2001-05-28 CN CN01810620A patent/CN1431901A/zh active Pending
- 2001-05-28 CA CA002410618A patent/CA2410618A1/en not_active Abandoned
- 2001-05-28 BR BR0111271-6A patent/BR0111271A/pt not_active Application Discontinuation
- 2001-05-28 EP EP04013380A patent/EP1468686B1/de not_active Expired - Lifetime
- 2001-05-28 WO PCT/IB2001/000933 patent/WO2001091756A2/en not_active Ceased
- 2001-05-28 MX MXPA02011862A patent/MXPA02011862A/es active IP Right Grant
- 2001-05-28 AT AT01932011T patent/ATE343387T1/de not_active IP Right Cessation
- 2001-05-28 DK DK04013380T patent/DK1468686T3/da active
- 2001-05-28 PL PL01365576A patent/PL365576A1/xx unknown
- 2001-05-28 NZ NZ551012A patent/NZ551012A/en unknown
- 2001-05-28 EP EP01932011A patent/EP1286672B1/de not_active Expired - Lifetime
- 2001-05-28 AU AU2001258690A patent/AU2001258690A1/en not_active Abandoned
- 2001-05-28 AT AT04013380T patent/ATE345818T1/de not_active IP Right Cessation
- 2001-05-28 DE DE60124093T patent/DE60124093D1/de not_active Expired - Lifetime
- 2001-05-28 ES ES04013380T patent/ES2277170T3/es not_active Expired - Lifetime
- 2001-05-28 JP JP2001587771A patent/JP2003534381A/ja not_active Withdrawn
- 2001-05-28 HU HU0301747A patent/HUP0301747A2/hu unknown
- 2001-05-28 IL IL15278201A patent/IL152782A0/xx active IP Right Grant
- 2001-05-28 CZ CZ20023860A patent/CZ20023860A3/cs unknown
- 2001-05-31 AP APAP/P/2001/002180A patent/AP1831A/en active
- 2001-05-31 HN HN2001000119A patent/HN2001000119A/es unknown
- 2001-05-31 PE PE2001000504A patent/PE20011329A1/es not_active Application Discontinuation
- 2001-05-31 DO DO2001000181A patent/DOP2001000181A/es unknown
- 2001-05-31 UY UY26742A patent/UY26742A1/es not_active Application Discontinuation
- 2001-05-31 AP AP2005003272A patent/AP1747A/xx active
- 2001-06-01 SV SV2001000473A patent/SV2002000473A/es not_active Application Discontinuation
- 2001-06-01 AR ARP010102641A patent/AR028937A1/es unknown
- 2001-06-01 PA PA20018518301A patent/PA8518301A1/es unknown
- 2001-06-04 US US09/873,973 patent/US20060287336A1/en not_active Abandoned
2002
- 2002-11-11 IL IL152782A patent/IL152782A/en not_active IP Right Cessation
- 2002-11-12 BG BG107267A patent/BG107267A/bg unknown
- 2002-11-14 IS IS6619A patent/IS6619A/is unknown
- 2002-11-28 ZA ZA200209665A patent/ZA200209665B/en unknown
- 2002-11-29 NO NO20025760A patent/NO325077B1/no unknown
- 2002-11-29 MA MA26927A patent/MA26908A1/fr unknown
- 2002-11-29 EC EC2002004369A patent/ECSP024369A/es unknown
2007
- 2007-02-08 CY CY20071100161T patent/CY1105992T1/el unknown
- 2007-11-14 JP JP2007296039A patent/JP2008056700A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
BG107267A (bg)	2003-06-30
MXPA02011862A (es)	2003-04-10
CY1105992T1 (el)	2011-04-06
EP1698338B1 (de)	2008-04-09
WO2001091756A3 (en)	2002-09-26
SV2002000473A (es)	2002-10-24
CA2410618A1 (en)	2001-12-06
IL152782A0 (en)	2003-06-24
PT1698338E (pt)	2008-06-03
NZ551012A (en)	2008-04-30
UA79425C2 (en)	2007-06-25
PL365576A1 (en)	2005-01-10
NO20025760L (no)	2003-01-15
DOP2001000181A (es)	2002-04-15
PE20011329A1 (es)	2002-01-15
DE60124791T2 (de)	2007-09-13
ATE391507T1 (de)	2008-04-15
ES2277170T3 (es)	2007-07-01
YU90702A (sh)	2005-11-28
EP1286672B1 (de)	2006-10-25
WO2001091756A2 (en)	2001-12-06
AR028937A1 (es)	2003-05-28
SI1468686T1 (sl)	2007-04-30
EP1468686B1 (de)	2006-11-22
AP1747A (en)	2007-05-31
AU2001258690A1 (en)	2001-12-11
SK16622002A3 (sk)	2004-07-07
GEP20053512B (en)	2005-05-10
EE200200670A (et)	2004-08-16
ZA200209665B (en)	2003-11-28
EP1698338A2 (de)	2006-09-06
PT1468686E (pt)	2007-01-31
EP1468686A2 (de)	2004-10-20
MA26908A1 (fr)	2004-12-20
NO325077B1 (no)	2008-01-28
EA007068B1 (ru)	2006-06-30
PA8518301A1 (es)	2002-09-17
KR20030007824A (ko)	2003-01-23
UY26742A1 (es)	2001-12-28
JP2008056700A (ja)	2008-03-13
US20060287336A1 (en)	2006-12-21
CZ20023860A3 (cs)	2004-01-14
BR0111271A (pt)	2003-06-10
EP1468686A3 (de)	2004-12-01
NO20025760D0 (no)	2002-11-29
AP1831A (en)	2008-02-26
HN2001000119A (es)	2001-09-11
EA200201168A1 (ru)	2003-06-26
HUP0301747A2 (hu)	2003-09-29
EP1286672A2 (de)	2003-03-05
IS6619A (is)	2002-11-14
JP2003534381A (ja)	2003-11-18
EP1698338A3 (de)	2006-09-20
DE60124093D1 (de)	2006-12-07
ATE345818T1 (de)	2006-12-15
ATE343387T1 (de)	2006-11-15
HRP20020953A2 (en)	2005-02-28
ECSP024369A (es)	2003-02-06
DK1468686T3 (da)	2007-03-12
DE60133596D1 (de)	2008-05-21
OA12267A (en)	2004-01-20
AP2005003272A0 (en)	2005-03-31
IL152782A (en)	2007-10-31
CN1431901A (zh)	2003-07-23

Publication	Publication Date	Title
DE60113496D1 (de)	2006-02-02	Verwendung von Glycyrrhizin zur Behandlung von Mastitis.
ATE275145T1 (de)	2004-09-15	Chinazolinderivate zur behandlung von tumoren
DE60124302D1 (de)	2006-12-14	Thiazolderivate zur behandlung von ppar-lierte krankheiten
DE60019556D1 (de)	2005-05-25	2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60019555D1 (de)	2005-05-25	2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60218493D1 (de)	2007-04-12	Substituierte 7-aza-ä2.2.1übicycloheptane für die behandlung von krankheiten
DE69936335D1 (de)	2007-08-02	Verwendung von morpholinol zur behandlung von sexuellen funktionsstörungen
ATE451921T1 (de)	2010-01-15	Phenylindole zur behandlung von hiv
DE60136477D1 (de)	2008-12-18	Retinoide zur behandlung von emphysem
ATE410430T1 (de)	2008-10-15	2,3-dihydro-6-nitroimidazoä2,1- büoxazolverbindungen zur behandlung von tuberkulose
DE60019158D1 (de)	2005-05-04	Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien
DE60208221D1 (de)	2006-01-26	Heterozyklische verbindungen zur behandlung von harnwegserkrankungen
DE60130365D1 (de)	2007-10-18	Die Verwendung von Rosiglitazon zur Behandlung von psychiatrischen Erkrankungen.
DE60218451D1 (de)	2007-04-12	15-keto-prostaglandine zur behandlung arzneimittelinduzierter obstipation
ATE279386T1 (de)	2004-10-15	Retinoide zur behandlung von emphysem
DE60214355D1 (de)	2006-10-12	Exemestan zur behandlung von hormonabhängigen störungen
DE60238765D1 (de)	2011-02-10	Carbamatverbindungen zur behandlung von schmerz
DE50105735D1 (de)	2005-04-28	Chlorzoxazon zur behandlung von psoriasis
ATE273276T1 (de)	2004-08-15	Cyclobutendion-derivate zur behandlung von artherosclerose
DE50205466D1 (de)	2006-02-02	Substituierte 2,5-diamidoindole als ece-inhibitoren zur behandlung von kardiovaskulären erkrankungen
ATE312104T1 (de)	2005-12-15	Verbindungen zur behandlung von beeinträchtigten fundischen entspannung
DE60021252D1 (de)	2005-08-18	Antikonvulsiva zur behandlung von autismus
ATE390134T1 (de)	2008-04-15	(+)-alpha-(2,3-dimethoxyphenyl)-1-(2-(4- fluorophenyl)ethyl)-4-piperidinemethanol oder prodrug davon zur behandlung von demenzsymptomen oder kognitiven störungen
DE60117122D1 (de)	2006-04-20	Verwendung von mirtazapin zur behandlung von schlafstörungen
ATE230741T1 (de)	2003-01-15	3-tetrahydropyridin-4-yl-indole zur behandlung von psychotischen störungen

Legal Events

Date	Code	Title	Description
2007-12-13	8364	No opposition during term of opposition
2010-03-25	8339	Ceased/non-payment of the annual fee